Wilmington Savings Fund Society’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.7M Sell
223,656
-2,920
-1% -$342K 0.64% 39
2026
Q1
$27.3M Sell
226,576
-10,115
-4% -$1.17M 0.65% 36
2025
Q4
$24.9M Sell
236,691
-3,282
-1% -$308K 0.58% 42
2025
Q3
$20.1M Sell
239,973
-40,319
-14% -$3.32M 0.49% 52
2025
Q2
$22.2M Sell
280,292
-13,849
-5% -$1.1M 0.39% 55
2025
Q1
$26.4M Sell
294,141
-8,277
-3% -$773K 0.49% 45
2024
Q4
$30.1M Sell
302,418
-11,535
-4% -$1.19M 0.54% 42
2024
Q3
$35.7M Buy
313,953
+174,419
+125% +$20.7M 0.64% 32
2024
Q2
$17.3M Sell
139,534
-1,305
-0.9% -$168K 0.66% 40
2024
Q1
$18.6M Buy
+140,839
New +$17.4M 0.71% 38
2023
Q3
$15.1M Sell
147,120
-921
-0.6% -$99.3K 0.67% 39
2023
Q2
$17.1M Sell
148,041
-2,416
-2% -$274K 0.71% 36
2023
Q1
$16M Sell
150,457
-3,482
-2% -$376K 0.71% 33
2022
Q4
$17.1M Sell
153,939
-1,570
-1% -$160K 0.78% 33
2022
Q3
$13.4M Sell
155,509
-306
-0.2% -$27.3K 0.65% 39
2022
Q2
$14.2M Sell
155,815
-18,075
-10% -$1.6M 0.65% 39
2022
Q1
$14.3M Sell
173,890
-15,584
-8% -$1.23M 0.56% 46
2021
Q4
$14.5M Sell
189,474
-6,690
-3% -$533K 0.52% 54
2021
Q3
$14.7M Sell
196,164
-2,217
-1% -$169K 0.57% 50
2021
Q2
$15.4M Sell
198,381
-11,571
-6% -$861K 0.59% 47
2021
Q1
$15.4M Sell
209,952
-6,155
-3% -$454K 0.62% 46
2020
Q4
$16.9M Sell
216,107
-19,672
-8% -$1.5M 0.71% 39
2020
Q3
$18.7M Buy
235,779
+10,894
+5% +$853K 0.87% 31
2020
Q2
$16.6M Sell
224,885
-2,398
-1% -$181K 0.82% 33
2020
Q1
$16.7M Buy
227,283
+36,256
+19% +$2.85M 0.98% 27
2019
Q4
$16.6M Sell
191,027
-6,481
-3% -$532K 0.84% 39
2019
Q3
$15.9M Sell
197,508
-2,913
-1% -$233K 0.87% 36
2019
Q2
$16M Buy
200,421
+3,040
+2% +$233K 0.87% 35
2019
Q1
$15.7M Buy
197,381
+54
+0% +$4.04K 0.85% 36
2018
Q4
$14.4M Sell
197,327
-29
-0% -$2.05K 0.87% 32
2018
Q3
$13.4M Buy
197,356
+1,326
+0.7% +$84.5K 0.7% 41
2018
Q2
$11.4M Buy
196,030
+1,685
+0.9% +$95.1K 0.63% 50
2018
Q1
$10.1M Sell
194,345
-1,804
-0.9% -$97.4K 0.58% 54
2017
Q4
$10.5M Sell
196,149
-3,470
-2% -$192K 0.57% 56
2017
Q3
$12.2M Sell
199,619
-659
-0.3% -$40K 0.7% 44
2017
Q2
$12.2M Sell
200,278
-1,399
-0.7% -$85.2K 0.73% 42
2017
Q1
$12.2M Sell
201,677
-841
-0.4% -$51K 0.74% 41
2016
Q4
$11.4M Buy
202,518
+4,063
+2% +$238K 0.71% 43
2016
Q3
$11.8M Buy
198,455
+2,155
+1% +$126K 0.74% 41
2016
Q2
$10.8M Sell
196,300
-10,908
-5% -$581K 0.69% 44
2016
Q1
$10.5M Sell
207,208
-2,830
-1% -$139K 0.67% 44
2015
Q4
$10.6M Buy
210,038
+8,604
+4% +$434K 0.66% 45
2015
Q3
$9.49M Buy
201,434
+242
+0.1% +$12.9K 0.61% 51
2015
Q2
$10.9M Sell
201,192
-9,284
-4% -$521K 0.63% 52
2015
Q1
$11.5M Sell
210,476
-1,194
-0.6% -$67.6K 0.66% 49
2014
Q4
$11.5M Buy
211,670
+1,890
+0.9% +$105K 0.64% 51
2014
Q3
$11.9M Sell
209,780
-3,138
-1% -$176K 0.67% 49
2014
Q2
$11.8M Sell
212,918
-5,627
-3% -$307K 0.65% 49
2014
Q1
$11.8M Sell
218,545
-6,870
-3% -$356K 0.66% 47
2013
Q4
$10.8M Sell
225,415
-3,893
-2% -$178K 0.61% 51
2013
Q3
$10.4M Buy
229,308
+2,428
+1% +$111K 0.64% 50
2013
Q2
$10.1M Buy
+226,880
New +$10.1M 0.65% 49

Other funds holding MRK

Wilmington Savings Fund Society's MRK Position: Q2 2026 in Review

Wilmington Savings Fund Society reduced its Merck (MRK) stake by 1.3% in Q2 2026, selling an estimated $342K and leaving 223,656 shares worth $28.7M. The position accounts for 0.64% of the portfolio, ranked #39.

Wilmington Savings Fund Society first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $35.7M in Q3 2024. 1,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Wilmington Savings Fund Society held 223,656 shares of Merck worth $28.7M as of Q2 2026.
  • Wilmington Savings Fund Society sold 2,920 Merck shares in Q2 2026, an estimated $342K.
  • Merck made up 0.64% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #39 holding.
  • Wilmington Savings Fund Society first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Wilmington Savings Fund Society's Merck position peaked at $35.7M in Q3 2024.
  • 1,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.